US Patent Issued to Stylianos Michalakis on March 11 for "Gene therapy for the treatment of CNGB1-linked retinitis pigmentosa" (German Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,246,072, issued on March 11, was assigned to Stylianos Michalakis (Munich).

"Gene therapy for the treatment of CNGB1-linked retinitis pigmentosa" was invented by Stylianos Michalakis (Munich) and Martin Biel (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a polynucleotide comprising a promoter comprising a human photoreceptor-specific promoter element, a core promoter and at least one transgene. Further, the invention provides a plasmid comprising the polynucleotide, a viral vector comprising the polynucleotide and a pharmaceutical composition comprising the polynucleotide. The invention also relates to the plasm...